ArticleArthritis research & therapy2023

Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis-results from two randomized controlled trials.

Helena Port et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.